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Abstract 
 
Matrix Gla Protein (MGP) is an ECM molecule commonly associated with dysfunctions 
of large blood vessels such as arteriosclerosis and atherosclerosis.  However, the exact 
role of MGP in the microvasculature is not clear.  Utilizing a mouse MGP knockout 
model we found that MGP suppresses angiogenic sprouting from mouse aorta, restricts 
microvascular density in cardiac and skeletal muscle, and is an endogenous inhibitor of 
tumor angiogenesis.  Similarly, morpholino based knockdown of MGP in zebrafish 
embryos caused a progressive loss of luminal structures in intersegmental vessels, a 
phenotype reminiscent of Dll4/Notch inhibition.  Accordingly, MGP suppressed Notch-
dependent Hes-1 promoter activity and expression of Jagged1 mRNA relative to Dll4 
mRNA.  However, inhibition of BMP but not Notch or VEGF signaling reversed the 
excessive angiogenic sprouting phenotype of MGP knockout aortic rings suggesting that 
MGP may normally suppress angiogenic sprouting by blocking BMP 
signaling.  Collectively, these results suggest that MGP is a multi-functional inhibitor of 
normal and abnormal angiogenesis that may function by coordinating with both Notch 
and BMP signaling pathways. 
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Introduction 
 
Angiogenesis is the development of new capillaries from pre-existing vessels. Normally, existing vasculature 
is stable and quiescent, held in stasis by a balance between pro- and anti-angiogenic molecules present in the 
vascular basement membrane and surrounding stroma. During angiogenesis, however, increasing pro-
angiogenic stimuli present in the microenvironment upsets this balance and activates angiogenesis by binding 
to specific receptors present on endothelial cell surfaces. Upon activation, endothelial cells begin to loose their 
cell-to-cell adhesions, proliferate, dedifferentiate, and sprout toward the avascular microenvironment. During 
the terminal phase of angiogenesis, endothelial cells re-differentiate, cease extraneous sprouting, organize 
themselves to form tubular structures, reconstitute a basement membrane, recruit mural cells (pericytes and 
vascular smooth muscle cells), re-establish cell-cell junctions, and return to cellular quiescence to form a stable 
vasculature (Carmeliet, 2000).  
 
Inappropriate angiogenesis is involved in the pathogenesis of several diseases including cancer (Cao, 2009; 
Carmeliet and Jain, 2000; Dreyfus, 1989; Folkman, 2001). Therefore, therapeutic manipulation of 
angiogenesis represents an attractive approach for the treatment of these diseases. In order to improve 
angiogenic therapeutics however, the identification of both pro as well as anti-angiogenic molecules and 
characterization of their mechanism of action is important. Interestingly, extracellular matrix (ECM) not only 
provides a scaffold to the growing endothelial cells but also contains distinct angiogenic signals to initiate, 
drive, and complete angiogenic process (Davis and Camarillo, 1995; Davis and Senger, 2005). Indeed, several 
extracellular matrix (ECM) molecules have been identified as angiogenic regulators (Ingber, 1992; Sottile, 
2004; Stupack and Cheresh, 2002; Stupack and Cheresh, 2003). Therefore, the complete characterization of 
ECM-based angiogenic molecules, and the molecular mechanism by which these molecules regulate 
angiogenesis represents an important, yet underdeveloped avenue towards potential angiogenic-based 
therapeutics.  
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Matrix Gla Protein (MGP) is an ECM molecule commonly found near vascular tissues (Hao et al., 2004; Luo 
et al., 1997; Yao et al., 2010). Primarily, MGP has been described as a calcification inhibitor and is crucial for 
the maintenance of normal vascular function (Luo et al., 1997; Yao et al., 2007). MGP -/- mice show severe 
aortic calcification and uniformly die within two months of birth (Luo et al., 1997). In addition, MGP 
polymorphisms have been linked to coronary artery calcification (Crosier et al., 2009; Herrmann et al., 2000), 
and MGP suppresses the formation of atherosclerotic lesions in the apolipoprotein E (APOE) knockout mouse 
model of human atherosclerosis (Yao et al., 2010). Mechanistically, MGP sequesters BMP2 and BMP4, 
thereby blocking BMP signaling through ALK receptors (Yao et al., 2006). However, it is not clear whether 
MGP suppresses vascular calcification via inhibition of BMP signaling alone or if additional mechanisms may 
be involved. In light of this, a recent discovery suggested that BMP alone is insufficient to promote smooth 
muscle calcification. Rather, BMP requires cooperation with the notch signaling pathway to promote vascular 
calcification (Shimizu et al., 2009; Shimizu et al., 2011).  This observation is further supported by results 
showing that signaling through the BMP and Notch pathways synergistically suppress VEGF expression 
(Larrivee et al., 2012; Ricard et al., 2012). 
 
MGP is not only physiologically important in large blood vessels, but also appears to be an important regulator 
of capillary function and angiogenesis. MGP suppresses excessive branching of pulmonary capillaries during 
vascular development in mice (Yao et al., 2007). Furthermore, MGP is differentially expressed during 
angiogenesis (Albig et al., 2007; Glienke et al., 2000; Javerzat et al., 2009) and is increased in tumor 
vasculature where it appears to promote tumor angiogenesis in glioblastoma (Kuzontkoski et al., 2010). 
Finally, MGP deficiency in mice has been shown to cause arteriovenous malformations in lungs and kidneys 
(Yao et al., 2011). Collectively, MGP has been broadly implicated in angiogenesis and vascular biology but its 
exact role in this context is unclear. Therefore, the main goal of this study is to investigate a more direct role 
for MGP during angiogenesis.  
 
Here, we show that MGP suppresses excessive endothelial sprouting, maintains stable vascular luminal 
structures, prevents excessive microvascular densities, and reduces tumor angiogenesis. Mechanistically, we 
find that MGP suppresses notch signaling suggesting that MGP may mediate vascular quiescence at least in 
part by blocking BMP and notch signaling. Collectively, these results suggest that MGP re-enforces vascular 
quiescence and promotes angiogenic resolution.  
 
Materials and Methods 
 
Ethics Statement 
Animal studies were performed in accordance with the animal protocol procedures approved by the 
Institutional Animal Care and Use Committee of Indiana State University (protocol #1-19-2008:AA and 11-
08-2007:AA). 
Mouse Breeding and Genotyping  
 
MGP -/+ mice in C57BL/6 background were generously provided by Gerard Karsenty (Columbia University 
Medical Center, NY). MGP -/+ mice were crossed with wild type C57BL/6 mice and the siblings were crossed 
to produce MGP -/- mice. Genotype was determined by PCR amplification of DNA from ear tissue using 
DirectPCR Lysis Reagent (Viagen Biotech, Inc., LA, CA). PCR was performed using specific primers 
targeting wild type vs. mutant MGP alleles. The wild type primer pairs targeted a 450 bp wild type MGP allele 
whereas the mutant primer pairs targeted a 1 Kb MGP mutant allele. Wild type and mutant PCR reactions were 
performed separately using the following conditions: 1 μl template DNA (from ear sample), 100 nM primers, 
1X standard buffer, 320 μM dNTPs, and 66 U/ml Taq polymerase (New England Bio Labs Inc.), and total 
volume 25 μl. Reactions were cycled according to the following conditions: 94oC for 2 min (1X); [94oC for 45 
sec; 57
o
C for 40 sec; 72
o
C for 60 sec] (35X); 72
o
C for 5 min (1X); and 4
o
C.  
 
 
 
 
2
  
Aortic Ring Angiogenesis Assay 
 
Aortas extending from the aortic arch to the diaphragm were removed from five week old C57BL/6 wild type 
or MGP -/- mice. The aortic sections were washed in 1X PBS and dissected into small rings of equal sizes 
(~1mm) before implantation into fibrin gels. Fibrin gels were prepared by mixing 1.5 mg/ml fibrinogen with 
serum free EGM2 media (Lonza Inc.), and filtering through 0.22 μm sterile filters. The fibrin gel was formed 
by adding 0.06 U/ml Thrombin to 0.5 ml fibrinogen solution in 24-well plates into which the aortic rings was 
immediately implanted. Fibrin gels were allowed to form at room temperature for 20 minutes before being 
overlaid with 1 ml EGM2 + growth factors (Lonza Inc.). The plates were incubated in 37
 o
C in a 5% CO2 
incubator. Aortic rings were observed daily for signs of angiogenic sprouting. Individual sprout lengths were 
measured after 10 days after brief staining with a 0.2% solution of p-iodo-nitrotetrazolium dissolved in 0.5% 
ethanol to stain live cells. 
 
MGP morpholino injection in zebrafish 
 
The MGP specific anti-sense morpholino (Genetools) (5’ GAGACACACACATG ACTGCAGGAGC 3’) was 
designed to interfere with MGP mRNA translation initiation. Morpholinos were dissolved in water and diluted 
1:1 into 0.1% phenol red/water injecting solution. 12 ng of MGP morpholino was injected into 1 to 8 cell Fli1-
GFP/GATA1-RFP embryos in a total volume of 0.9 nl per embryo. Embryos were sedated in tricaine and 
monitored for vascular phenotypes on a Nikon SMZ-1500 fluorescent dissecting microscope. Morpholinos 
directed against p53 were synthesized and used according to previously published work (Robu et al., 2007). 
 
Immunohistochemistry 
 
Excised tissues were fixed in 4% paraformaldehyde for 1 hr and stored in 70% ethanol before paraffin 
embedding, sectioning, and staining with CD-31 antibody to visualize vascular structures in the Clarian 
Pathology Laboratory at Indiana University (Indianapolis, IN). To quantitate vascular density, CD-31 staining 
patterns were traced onto white paper with black ink and the resulting copy was scanned to obtain total 
vascular area using Image J software (NCBI). 
 
Immunobloting 
 
The N-terminally Flag-tagged human MGP (N-Flag-hMGP) plasmid was generously provided by Dr. Kristina 
Bostrom (UCLA, CA). Approximately, seventy five percent confluent 293T cells in 10 cm plates were 
transfected with 10 µg of N-Flag-hMGP plasmid DNA using Trans-IT LT1 transfection reagents (Mirus Inc.) 
as per the manufacturer’s recommendations. After 24 hours, plates were washed with 1X PBS and cultured in 
serum free media (SFM) overnight. Confirmation of MGP expression in the conditioned media was performed 
by precipitation with .1% DOC/TCA as described in our previous study (Williams et al., 2010) followed by 
western blot analysis using anti-flag M2-antibody.  
 
RT-PCR 
 
RT-PCR was performed to determine the expression of Delta Like-4 (DLL4), jagged-1, Hes-1, CD31, smooth 
muscle Actin, MGP, and GAPDH. Total RNA was isolated using Trizol reagents (Life technologies, Grand 
Island NY) as per the manufacturer’s instructions. cDNA was synthesized using the iScript cDNA Synthesis 
Kit (Bio Rad Inc.). Primer sequences, target genes, and PCR product sizes for each primer set are listed in 
Table 1. The PCR reactions were performed under the following conditions: 10 ng cDNA; 200 nM oligos; 320 
µM dNTP; 1x standard buffer; and 66 U/ml Taq Polymerase in a total reaction volume of 25 µl. Cycling 
parameters used were as follows: 1 cycle at 94
o
C for 2 min; 30 cycles at 94
o
C for 45 sec, 57
o
C for 40 sec, and 
72
o
C for 60 sec; 1 cycle at 72
o
C for 5 min; and hold at 4
o
C.  
 
Transfections and Luciferase Assay 
 
Transient transfection of human microvascular endothelial cells (HMEC) was performed in triplicate in 24-
well plates. HMEC cells were seeded into 24-well plates at 20,000 cells/well 20-24 hrs prior to transfection. 
Individual wells were transfected in triplicate with 200 ng of Hes-1 luciferase plasmid and 25 ng of CMV β-
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galactosidase control plasmid using Trans-IT LT-1 (Mirus Inc.) reagent according to the manufacturer’s 
recommendations. Two days after transfection, the cells were lysed in 100 µl/well of Passive Lysis Buffer 
(Promega, Madison, WI), freeze-thawed, and centrifuged for 1 minute. Luminescence activities for luciferase 
and β-galactosidase were measured by Glomax Luminometer using  Promega luciferase assay reagents 
according to the manufacturer’s recommendations.  
 
In-vivo Tumor Growth Studies 
 
Pancreatic Adenocarcinoma (PanO2) cells were resuspended in sterile phosphate buffered saline (PBS) and 
1x10
6
 cells per 100 μl were injected subcutaneously between the shoulder blades of approximately 10-week-
old MGP -/+ and MGP +/+ C57BL/6 mice (three mice per condition; bred in-house). Mice were monitored on 
a daily basis and primary tumors were measured externally with calipers between days 9 and 17.  
 
Results 
 
MGP suppresses endothelial-sprouting in-vitro 
 
In our previous study, MGP expression was significantly increased during angiogenesis, but the exact role of 
MGP in this context was not clear (Albig et al., 2007). Here, we used MGP deficient mice to study MGP 
function during angiogenesis. PCR based genotyping was used to identify MGP -/- mice and RT-PCR analysis 
was used to confirm the absence of MGP mRNA in MGP-/- animals (Figure S1).  Aortas were isolated from ~ 
5 week old MGP +/+ or MGP -/- mice, sectioned, and implanted into fibrin gels.  As shown in fig 1A and B,  ~ 
40% of the MGP -/- rings initiated sprouting on day 3 while MGP +/+ rings did not initiate sprouting until day 
4. Furthermore, 100% of the aortic rings from MGP -/- mice had sprouted by day 5 whereas 100% of the MGP 
+/+ rings only sprouted by day 7. Finally, after ten days in culture, angiogenic sprouts from MGP -/- rings 
were ~1.5 fold longer compared to angiogenic sprouts from MGP +/+ rings (Fig 1C).  To determine if MGP 
was directly responsible for suppressing aortic sprouting, we generated control or MGP containing conditioned 
media by transfection of 293T cells (Figure S1) and applied these conditioned medias to MGP+/+ and MGP-/- 
aortic ring cultures.  As shown in figure 1, compared to control conditioned media MGP containing 
conditioned media delayed sprouting initiation and decreased final sprout length in both MGP+/+ and MGP-/- 
aortic cultures.  Collectively, these results showed that MGP normally acts to suppress angiogenic sprouting 
and suggested that either 1.) MGP is an endogenous inhibitor of angiogenesis, or 2.) that MGP does not inhibit 
angiogenesis per se, but rather is important for re-enforcing angiogenic resolution.  
 
 MGP suppresses microvascular density in heart and skeletal muscles  
 
Based on the increased sprouting from MGP -/- rings, we predicted that MGP -/- mice might have increased 
vascular densities compared to MGP +/+ mice. To investigate this, we isolated various tissues from MGP +/+ 
and MGP -/- mice and used immunohistochemistry with anti-CD31 antibodies to monitor vascular density. 
Compared to the MGP +/+ mice, MGP -/- mice had significantly increased CD-31 staining in heart (2.8 fold 
increase) and skeletal muscles (1.7 fold increase) (Fig 2A), suggesting that MGP inhibits formation of 
excessive microvasculature in these tissues.  These results suggested that MGP is crucial in the maintenance of 
normal vascular densities in skeletal muscle and heart and further emphasized the importance of MGP in 
microvascular function.  
 
MGP suppresses tumor angiogenesis 
 
In contrast to our results showing that MGP suppresses angiogenic sprouting, MGP was previously shown to 
promote tumor angiogenesis (Kuzontkoski et al., 2010).  These conflicting observations suggested that MGP 
may have differential roles in normal physiological and pathological angiogenesis and it was therefore 
important to distinguish between these possibilities.  To accomplish this, we subcutaneously injected 
pancreatic adenocarcinoma (PanO2) cells into syngeneic MGP +/+ or MGP heterozygous (MGP +/-) mice and 
monitored tumor growth and vascular density in the resulting tumors. Performing this experiment in MGP +/- 
mice was necessary since MGP -/- mice typically die by five weeks of age, which prohibits long-term tumor 
studies whereas -/+ mice have normal life spans.  As shown in figure 3, tumors grew significantly faster (Fig 
3A) and at dissection were approximately 2.5 fold larger in MGP +/- compared to tumors grown in MGP +/+ 
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mice (Fig 3B, C).  Immunohistochemistry of tumor sections with anti-CD31 antibodies (Fig 3D, 3E) and RT-
PCR analysis of CD31 mRNA (Fig 3F, 3G) revealed that MGP +/- tumors contained approximately 1.5 fold 
more blood vessels compared to tumors grown in control mice.  Therefore, these results are consistent with our 
previous results and do not support differential roles for MGP in normal vs. pathological angiogenesis. 
 
MGP is important for the maintenance of vascular lumen structures   
 
To further dissect the role of MGP in vascular function, we examined vascular development in zebrafish 
embryos injected with anti-MGP morpholinos. Multiple sequence alignment of MGP from seven different 
species including zebrafish indicated that MGP is highly conserved among species (Figure S2) and therefore 
suggested that MGP is likely to serve conserved functions in vascular development and function. RT-PCR was 
used to confirm expression of MGP mRNA in developing zebrafish. As shown in figure S2, MGP mRNA was 
expressed as early as 10 hours post fertilization (HPF) and continued to be expressed throughout the observed 
time period. This was consistent with previous observations that showed a similar pattern of MGP expression 
by immunohistochemistry in zebrafish (Gavaia et al., 2006). Within 24 hours after morpholino injections, 
MGP morphants showed a progressive developmental defect characterized by an abnormal curvature of the 
back.  A slightly curved phenotype was observed on day 1 (Fig 4A) that became more prominent by day 3 (Fig 
4B) and day 6 (Fig 4D).  MGP expression in zebrafish has been found in chondrocytes and is important for 
cartilage mineralization during bone formation (Gavaia et al, 2006).  In MGP -/- mice, MGP is important for 
suppressing pathological calcification of extracellular matrix (Lou et al, 1997).  Therefore it is likely that the 
deformation of MGP morphants is related to the role of MGP in cartilage and bone development. Importantly 
however, despite the curved phenotype, normal body segmentation was observed (Fig 4A), which is requisite 
for vascular development (Lawson et al., 2001).  Inspection of the vasculature revealed that MGP knockdown 
slightly delayed the angiogenic sprouting of intersegmental vessels (ISV) from aorta on day one (Fig 4A). 
However, by day 3 ISV vessels in MGP morphants were similar to those in control fish suggesting MGP is 
dispensable for the initial establishment of vascular networks. This was consistent with our observations that 
MGP did not have an observable affect on activities operant during angiogenesis including invasion, 
proliferation, migration, and tube formation activity of endothelial cells (Figure S3). By day 3 however, MGP-
knockdown in the developing zebrafish caused a progressive loss of vascular luminal structures in the ISVs.  
Day 3 MGP morphants had narrower ISV lumens compared to control fish (Fig 4C, arrows) and blood flow 
was partially blocked (Fig 4B). By day 6, luminal structures in MGP morphant aortas and ISVs were 
completely non-evident compared to the control fish (Fig D, E) and MGP morphants developed edema near 
the anterior side of the heart (Fig 4D, arrow).  Overall, these results suggested that MGP is not required for 
initial vascular development but is crucial for proper maintenance of normal vascular structure.  
MGP decreases Notch signaling in cultured endothelial cells. 
 
Notch activation by DLL4 and jagged-1 has opposing effects on endothelial sprouting during angiogenesis. 
Jagged-1 promotes endothelial sprouting and angiogenesis whereas DLL4 suppresses sprouting and promotes 
vascular quiescence (Benedito et al., 2009). Interestingly, DLL4 knockdown in zebrafish (Leslie et al., 2007), 
DLL4 -/+ mice (Scehnet et al., 2007), and Dll4 blockade (Noguera-Troise et al, 2006) all exhibit excessive 
angiogenesis and loss of vascular lumen structures similar to our results with MGP -/- aortic rings and MGP 
morphants and  suggested a link between MGP and notch signaling. To test this, we utilized a notch responsive 
luciferase construct featuring the Hes-1 promoter upstream of the luciferase gene to examine notch responsive 
transcription activity in Human Microvascular Endothelial cells (HMEC) cultured in control or MGP 
conditioned media. MGP containing conditioned media was prepared by transfection of MGP cDNA into 293T 
cells and expression was confirmed by western blot (Fig S1). Our luciferase data showed that HMECs cultured 
in MGP conditioned media had decreased Hes-1 activity compared to the control HMECs cultured in control 
conditioned media (Fig 5A). To support this observation, we performed RT-PCR analysis to determine if MGP 
controls expression of different components of the notch signaling pathway. To accomplish this, 10 day old 
aortic ring cultures from MGP +/+ and MGP -/- mice were collected by tryptic digestion of fibrin gels, 
removal of the original aortic ring, and extractions of RNA from the remaining outgrowths. RT-PCR analysis 
was performed to compare expression levels of smooth muscle actin (smActin), endothelial cell marker (CD-
31), GAPDH, the Notch target gene Hes-1, and the notch ligands jagged-1 and DLL4. RT-PCR detected 
expression of both smooth muscle actin (smActin) and CD-31, confirming that aortic outgrowths were co-
cultures of smooth muscle and endothelial cells (Fig 5B). More importantly however, expression of jagged-1 
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mRNA and Hes-1 mRNA in MGP -/- outgrowths was elevated compared to MGP +/+ outgrowths whereas 
expression of DLL4 mRNA remained unchanged (Fig 5B). Conversely, we also examined gene expression 
levels in HMEC cells treated with conditioned media collected from control or MGP transfected 293T cells 
(Fig 5C). Consistent with previous results, MGP significantly decreased expression of jagged-1 and Hes-1 
mRNA but did not affect DLL4 mRNA expression. Collectively, this data provided a correlation between 
MGP function and notch signaling and suggested that MGP might inhibit angiogenic sprouting by suppressing 
jagged-1 expression. 
 
MGP suppresses aortic sprouting independently of Notch and VEGF signaling. 
 
Our results have shown that MGP suppressed angiogenic sprouting and Notch signaling in cultured aortic rings 
and isolated endothelial cells. Previously, MGP was shown to suppress BMP signaling (Bostrom et al., 2004; 
Zebboudj et al., 2002). Interestingly, BMP and Notch signaling have been co-implicated in the development of 
vascular calcification (Shimizu et al., 2011), angiogenic sprouting (Moya et al., 2012) and BMP together with 
Notch are reported to synergistically suppress VEGF expression (Larrivee et al., 2012; Ricard et al., 2012). 
Based on these results, it was important to determine if enhanced aortic sprouting in the absence of MGP was a 
consequence of enhanced Notch, BMP, or VEGF signaling or a synergistic manipulation of these pathways.  
To address this question, we monitored sprouting from control or MGP -/- aortic rings in the presence or 
absence of either the BMP antagonist dorsomorphin, the -secretase/Notch antagonist DAPT, or the VEGF 
inhibitor SU5416. As previously shown, MGP -/- aortic sections demonstrated significantly enhanced aortic 
sprouting compared to aortic rings from control mice (Figure 6A). Surprisingly, inhibition of Notch signaling 
with DAPT or inhibition of VEGF signaling with SU5416 had a minimal effect on aortic sprouting from both 
control and MGP knockout aortic rings indicating these signaling mechanisms play a minor role for angiogenic 
sprouting in this assay.  However, inhibition of BMP signaling with dorsomorphin elicited a striking blockade 
on aortic sprouting from both control and MGP -/- aortic sections suggesting that BMP signaling is the 
predominant signaling system active under these conditions. Collectively, these results illustrated that MGP 
does not appear to normally suppress angiogenesis by decreasing Notch or VEGF signaling.  Unfortunately, 
the complete suppression of aortic sprouting in dorsomorphin treated aortic cultures limited our ability to 
determine if MGP normally suppresses angiogenesis by suppressing BMP signaling. 
 
Discussion 
 
Arteriosclerosis, atherosclerosis, and the inappropriate angiogenesis within tumors collectively account for 
some of the most common vascular abnormalities of humans. An important realization is that each of these 
diseases is strongly impacted by interactions between vascular cells and components of ECM in the vascular 
microenvironment. In light of this, growing interest has been shifted toward understanding the interplay 
between ECM and endothelial cell activity to dissect the pathophysiology of these vascular diseases.  
 
Matrix Gla protein is an ECM protein commonly found in vascular tissues (Hao et al., 2004; Luo et al., 1997; 
Yao et al., 2010) and has been implicated in several vascular abnormalities including arteriosclerosis, 
atherosclerosis, arterial-venous malformations, and abnormal tumor angiogenesis (Kuzontkoski et al., 2010; 
Luo et al., 1997; Yao et al., 2010; Yao et al., 2011). However, the functional role and mechanistic basis by 
which MGP impacts these abnormalities is unclear. In this study we used a combination of mice and zebrafish 
MGP knockout models coupled with cell and tissue culture approaches to refine our understanding of the role 
of MGP in vascular formation and function.    
 
In order to clarify the role of MGP in angiogenesis, we compared angiogenic sprouting from aortas dissected 
from wild type or MGP knockout mice. Angiogenesis encompasses both the activation phase wherein vascular 
networks are established by the proliferation, migration, and invasion of endothelial cells, and the resolution 
phase wherein vascular networks are stabilized and endothelial cell quiescence is established. Our results show 
that in the absence of MGP, aortic sprouts appeared significantly earlier and grew to greater lengths compared 
to control aortic rings (Figure 1). Similarly, Yao et al. showed that MGP suppresses pulmonary blood vessel 
branching (Yao et al., 2007). This observation suggested that either MGP normally functions to reinforce the 
resolution phase of angiogenesis or that MGP actively suppresses the activation phase of angiogenesis. Our 
data does not support the idea that MGP actively suppresses angiogenesis since we were unable to detect any 
impact of MGP on endothelial cell activities operant during angiogenesis including proliferation, invasion, 
6
  
migration, and capillary formation (Figure S3). Furthermore, our previous findings showed that MGP 
expression is increased during the later stages of endothelial network formation, consistent with a role during 
resolution phase (Albig et al., 2007). Finally, ISV sprouting in zebrafish embryos was only minimally 
impacted by MGP knockdown and the initial establishment of functional vascular networks was normal in 
MGP morphants (Figure 4B). Therefore, we hypothesize that MGP is important for the establishment and 
maintenance of the endothelial quiescence program. In support of this hypothesis, CD31 staining of MGP 
knockout adult tissues revealed increased vascular densities in heart and skeletal muscle, suggesting a failure 
of vascular tissues to achieve quiescence. In addition, tumors grown in MGP +/- mice contained more blood 
vessels than their control counterparts further illustrating the role of MGP in vascular development. Finally, 
the progressive loss of vascular lumens in MGP morphant zebrafish shows that MGP is indispensable for the 
maintenance of functional vascular lumen structures, an important aspect of quiescent vasculature. 
Collectively, these data suggest that MGP does not significantly impact angiogenesis activation, but rather is 
important during the resolution phase of angiogenesis.  
 
In mice, MGP blocks BMP-2/4/7 signaling (Yao et al., 2011; Yao et al., 2006).  In the absence of MGP, 
elevated BMP signaling has been linked to vascular defects including arteriosclerosis, atherosclerosis (Yao et 
al., 2010), and arterial-venous malformations (Yao et al., 2011).  However, in zebrafish embryos, it is not clear 
that MGP suppresses BMP since zebrafish MGP does not contain a BMP binding domain (Yao et al, 2008).  
Moreover, the role of BMP signaling in zebrafish intersegmental vessel formation is uncertain since the BMP 
responsive BRE promoter is not active in developing ISV vessels (Collery and Link, 2011), and specific 
inhibition of BMP has been shown to have no affect on ISV formation (Cannon et al., 2010) although BMP 
signaling has been implicated in angiogenic sprouting from the axial vein (Wiley et al., 2011).  Taken together, 
it is not likely that the effect of MGP knockdown on zebrafish ISV luminal structures is strictly due to 
abnormal BMP signaling.  Interestingly, BMP has been shown to function in synergy with Notch signaling 
(Larrivee et al., 2012; Moya et al., 2012) thus potentially implicating Notch with our results.  
 
Activation of Notch signaling by Jagged-1 or DLL4 initiates opposing angiogenic activities.  Although 
opposing, a balance between Dll4 and Jagged-1 is required to establish and maintain functional vasculature 
(Benedito et al., 2009).  DLL4 promotes quiescent stalk cell selection whereas jagged-1 opposes Dll4 by 
inducing pro-angiogenic tip cell selection in endothelial cells.  Disruption of this balance by Dll4 knockdown 
in zebrafish drives the initial establishment of functional vasculature followed by excessive angiogenic 
sprouting and the eventual loss of vascular lumen structures (Leslie et al., 2007). Similarly, blockade of notch 
ligand DLL4 has been implicated in the development of excessive but non-lumanized vessels in tumors (Li et 
al., 2007; Noguera-Troise et al., 2006). Similar to these results, we found that MGP morphants experienced a 
progressive loss of vascular lumen structures and that MGP-/- aortic rings exhibited excessive angiogenic 
sprouting compared to their control counterparts.  Based on these similarities, we hypothesized that MGP may 
function via the notch signaling pathway. In support of this hypothesis, our luciferase data revealed that MGP 
suppressed notch activation in endothelial cells. Moreover, our RT-PCR results from mouse aorta and HMEC 
cells showed that MGP suppressed Hes-1 and jagged-1 mRNA expression but did not alter DLL4 expression 
(Figure 5). Therefore, our findings suggested that MGP normally functions to maintain a balance between 
jagged-1 and DLL4 and that in the absence of MGP, excessive jagged-1 destabilizes stalk cell structures 
resulting in a failure to achieve a stable, quiescent vasculature.  Despite this data, BMP inhibition with 
dorsomorphin but not Notch inhibition with DAPT completely blocked angiogenic outgrowths from both 
MGP+/+ and MGP-/- mouse aorta (Figure 6).  Therefore, while our in vitro gene expression data and zebrafish 
morpholino data suggest that MGP functions through Notch in these systems, it is not yet clear if BMP, Notch, 
or an alternative signaling pathway is responsible for the enhanced sprouting observed in MGP -/- aortic ring 
cultures. 
 
MGP is not only associated with suppression of arteriosclerosis and atherosclerosis, but up-regulation of MGP 
has also been associated with poor prognosis in breast cancer (Yoshimura et al., 2009), gastric cancer (Guo et 
al., 2010) and glioblastoma (Kuzontkoski et al., 2010). MGP appears to be significantly up regulated in these 
cancers and is under evaluation as a potential prognostic marker. In glioblastoma, MGP appears to promote 
tumor growth, angiogenesis (Kuzontkoski et al., 2010), and migration of glioma cells (Mertsch et al., 2009). In 
contrast, our findings in pancreatic adenocarcinoma (PanO2) showed that tumors grew more rapidly and were 
more densely vascularized in MGP+/- mice compared to MGP+/+ mice (Figure 3), suggesting a pleiotropic 
role for MGP in various cancers. One possibility to explain these conflicting observations involves decreased 
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MGP expression in early stage tumors to enable angiogenesis, and increased MGP expression in larger tumors 
to promote vascular stabilization and increase tumor perfusion.  However, it is evident that additional 
experimentation is required to more precisely define the role of MGP in tumor growth and angiogenesis.  
 
In summary, we have presented evidence suggesting that MGP promotes angiogenic resolution and vascular 
stabilization. Our findings provide a new avenue toward understanding the role of MGP in both large as well 
as small vessel dysfunctions. We believe these results will shed light on the pathogenesis of vascular diseases 
in which MGP is involved such as tumor angiogenesis, atherosclerosis, arteriosclerosis, and arterial-venous 
malformation.  
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Figure Legends 
 
Figure 1. Matrix gla protein (MGP) suppresses endothelial sprouting in mouse aortic rings.  (A) Aortic 
rings from MGP +/+ and MGP -/- mice were implanted into fibrin gels, cultured for seven days, and 
photographed under low and high power magnification.  Shown are representative pictures from a single 
experiment that was performed four times in its entirety.  Each experiment consisted of 6-8 aortic ring sections 
harvested from an individual control or MGP-/- mouse.  B)  The initiation of aortic sprouting was monitored 
daily and graphed as a percentage of sprouting rings vs time.  Data presented are the average +/- SE of four 
independent experiments.  C)  Average sprout length after seven days in culture was measured using imageJ 
software.  Data represents average +/- SE of four independent experiments.  D) MGP+/+ and MGP-/- aortic 
rings were cultured in the presence or absence of control or MGP containing conditioned media collected from 
293T cells transfected with MGP cDNA or empty vector sequences.  Shown are representative images from a 
single experiment that was performed three times in its entirety.  Each experiment consisted of 3-4 MGP+/+ or 
MGP-/- rings in control or MGP containing conditioned media.  E)  Sprouting from MGP+/+ and MGP-/- 
aortic rings in the presence of control or MGP containing conditioned media was monitored daily and the 
resulting data is depicted as in B.  F) Average sprout length was measured and the resulting data is presented 
as in C.  In all experiments, * indicates P<.05, student’s t-test. 
 
Figure 2. MGP suppresses microvascular density in heart and skeletal muscles. A) Vascular density in heart 
and skeletal muscle was monitored by immunohistochemistry with anti-CD31 antibodies. Shown are 
representative images of a single experiment that was performed three times in its entirety. B) Quantification 
of CD-31 staining in heart tissue form MGP +/+ and MGP-/- mice was performed by imageJ analysis.  Data 
shown represents the average +/- SE of three independent experiments and is presented as the fold change 
compared to MGP+/+ tissue. C) CD31 staining in skeletal muscle (SKLM) was quantified and presented as in 
B. In both B and C, ** Indicates P<0.05, student’s-test.  
 
Figure 3. MGP suppresses tumor growth and vascular density. A) Tumor growth was initiated in MGP+/+ 
or heterozygous (MGP+/-) C57BL/6 mice by subcutaneous injection (in triplicate) of 1x10
6
 Pancreatic 
Adenocarcinoma (PanO2) cells. Tumor sizes were measured one week after injection and subsequently every 
other day.  Data shown depicts average daily tumor size +/- SE compared to tumors grown in control mice. B) 
Representative set of triplicate tumors from a single experiment that was performed three times in its entirety. 
C) Final tumors mass was recorded and is presented as the average fold change (+/-SE) compared to MGP+/+ 
tumor mass (N=3).  D)  Immunohistochemistry with anti-CD31 antibodies was used to monitor vascular 
densities in tumors from MGP+/+ and MGP+/- mice.  E) Anti-CD31 staining in tumors was quantified by 
imageJ analysis and is presented as the average (+/- SE) compared to MGP+/+ tumors. F) Total RNA was 
extracted from MGP+/+ and MGP+/- tumors and used for RT-PCR analysis of CD31 and GAPDH mRNA 
expression.  Shown are representative images of a single experiment that was performed three times in its 
entirety.  G) CD31 RT-PCR results were quantified by imageJ analysis and normalized by GAPDH signal.  
Data shown depicts CD31 expression in MGP+/- compared to MGP+/+ tumors and is the average (+/- SE) of 
three independent experiments.  In all panels, * indicates P<0.05, Student’s t-test. 
 
Figure 4. MGP stabilizes vascular structure in zebrafish embryos. Fli1-GFP/GATA1-RFP zebrafish 
embryos between 1 to 8 cells were injected with morpholino vehicle (water + .1% phenol red) (control) or 
equal volumes containing 12 ng of MGP anti-sense Morpholino (MGP MO). A) Bright field (BF) and 
endothelial network analysis (GFP) of ~24 hour post fertilization (hpf) embryos at low (middle panel) and high 
(right panel) magnification.  B)  Analysis of bright field (BF),  endothelial network (GFP), and flow dynamics 
(RFP) in 3 day post fertilization (dpf) embryos.  C) High power imaging of endothelial networks in 3 dpf 
embryos injected with either vehicle or MGP morpholinos.  Arrows indicate sites of endothelial lumen 
restriction in MGP morphant.   D)  Analysis of bright field (BF),  endothelial network (GFP), and flow 
dynamics (RFP) in 6 day post fertilization (dpf) embryos.  Arrow indicates site of edema accumulation in 
MGP morphant.  E) High power imaging of endothelial networks in 6 dpf embryos injected with either vehicle 
or MGP morpholinos. 
 
Figure 5. MGP suppresses notch signaling and blocks jagged-1 expression in sprouting endothelial cells. 
A)  Human microvascular endothelial cells (HMECs) were co-transfected with Hes-1 luciferase + CMV- βgal 
constructs were cultured either with control condition media (Cont) or MGP containing conditioned media 
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(MGP).  Data depict the average (+/-SE) of four independent experiments and are presented as the fold change 
relative to HMEC cells cultured in control conditioned media.  B) Total RNA was collected from sprouted 
MGP+/+ or MGP-/- aortic rings and used to perform RT-PCR analysis of smooth muscle actin (smActin), 
endothelial cell marker (CD-31), GAPDH, Notch target Hes-1, and notch ligands jagged-1 and Delta like 4 
(DLL4) genes.  Non-reverse transcribed samples were included as a negative control.  Shown are 
representative images of a single experiment that was performed four times in its entirety.  ImageJ analysis 
was used to compare Dll4, Jagged1, and Hes-1 mRNA in MGP+/+ and MGP-/- aortic rings (right panel).  Data 
shown is the average (+/-SE) of four experiments presented as fold change compared to MGP+/+ samples.  C)  
Total RNA was collected from HMECs cultured in conditioned media from 293T cells transfected with empty 
vector (Con), or MGP cDNA (MGP).   RT-PCR analysis was to monitor the relative mRNA expression levels 
of Hes-1, Jagged-1, D114, and GAPDH.  Non-reverse transcribed samples were included as a negative control.  
Shown are representative images from a single experiment that was performed three times in its entirety. 
ImageJ analysis was used to compare Dll4, Jagged1, and Hes-1 mRNA in the absence and presence of MGP 
(right panel).  Data shown is the average (+/-SE) of three experiments presented as fold change compared to 
MGP+/+ samples.  In all panels, * indicates P<.05, student’s t-test. 
 
Figure 6. MGP suppresses aortic sprouting independently of Notch and VEGF signaling.  Aortic rings 
were isolated from MGP+/+ or MGP-/- mice and embedded into fibrin gels containing either vehicle (DMSO), 
gamma-secretase Notch inhibitor (DAPT), broad spectrum BMP inhibitor dorsomorphin (Dorso), or VEGFR2 
inhibitor (SU5416).  Shown are representative images were collected after 10 days in culture from a single 
experiment that was performed three times in it’s entirety. 
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Supplementary Information 
 
Materials and Methods 
 
Invasion Assay 
For invasion assays, 100,000 endothelial cells suspended in control or MGP containing condition media were 
cultured (in triplicate) into the upper well of invasion chambers that were previously coated with matrigel 
basement membrane. To the lower well of the invasion chamber, EGM-2 media was added and the cells were 
incubated overnight. Assays were fixed the following day with 95% ethanol and the invading cells were 
stained with 1X crystal violet. The density of invading cells was measured by densitometry of scanned 
membranes using ImageJ (NCBI) software. 
 
Proliferation Assay  
For proliferation assay, 2000 endothelial cells/well were cultured in EGM2 growth media supplemented with 
condition medium containing either control (empty vector) or human MGP (Flag-hMGP) plasmids. Cell 
proliferation in triplicate wells were examined daily over the next two days by measuring the fluorescent 
conversion of WST1 cell proliferation reagent essentially as described in our previous publications (Albig et 
al., 2007).  
 
Capillary Formation Assay 
For capillary formation assay, 200,000 cells/ml were treated with conditioned (hMGP containing) or control 
(empty vector) media and cultured into a matrigel containing culture plate. Cells were incubated overnight at 
37C incubator.  
 
Wound Healing Assay 
Confluent plates of endothelial cells were scratched uniformly and were treated with conditioned (hMGP 
containing) or control (empty vector) media and cultured for few days. Wound healing was determined by 
relative migration of endothelial cells into the scratched region. 
 
Figure Legends 
Supplementary figure 1.   A) PCR based genotyping was used to identify MGP+/+, MGP+/-, and MGP-/- 
mice.  PCR amplified 450 bp MGP product in MGP +/+ (WT) mice and 1 Kb mutant DNA product in the 
MGP -/- (KO) mice. B) RT-PCR showing lack of MGP mRNA expression in aortic ring cultures.  C)  MGP 
containing conditioned media was made by transfecting 293T cells with empty vector or N-terminally flag 
tagged human MGP construct (N-Flag-hMGP). MGP overexpression in conditioned media was confirmed by 
western blot analysis of condition media using anti-flag antibody. 
 
Supplementary figure 2.   A) MGP protein sequences from Human, Mouse, Orangutan, Zebra finch, Zebrafish, 
Rat, and Pig were compared using the Praline sequence alignment tool 
(http://www.ibi.vu.nl/programs/pralinewww/). The degree of conservation for each amino acid is indicated by 
color according to the key and in the “conservation” line of the alignment where * indicates a fully conserved 
residue (i.e. 100% identity). Overall, the alignment showed 62% sequence identity over the entire length of the 
alignment.  B) MGP expression was detected in developing transgenic zebrafish (fli-1-GFP/GATA-1-RFP) 
embryos by RT-PCR analysis. cDNAs were generated from embryos ranging from 2 to 48 hours and subjected 
to RT-PCR analysis with MGP or GAPDH specific oligonucleotides.  
 
Supplementary Figure 3. MGP did not affect endothelial cell invasion, proliferation. capillary formation, or 
wound healing assays. Endothelial cells treated with MGP conditioned (MGP) or control (Cont) conditioned 
media were subjected to A) Invasion assay, B) Proliferation assay, C) Capillary formation assay, D) Wound 
healing assay. 
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